Barclays’s Nuvalent NUVL Stock Holding History

Barclays’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-24,000	Closed	-$1.88M	–	5456
2024 Q4	$1.88M	Buy	+24,000	New	+$2.24M	﹤0.01%	2935

Other funds holding NUVL

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Barclays's NUVL Position: Q2 2026 in Review

Barclays increased its Nuvalent (NUVL) stake by 4,012% in Q2 2026, buying an estimated $133M and bringing the position to 1,268,265 shares worth $157M. The position accounts for 0.03% of the portfolio, ranked #379.

Barclays first reported a position in NUVL in Q1 2022 and has held it in 18 quarters since. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

Barclays held 1,268,265 shares of Nuvalent worth $157M as of Q2 2026.
Barclays bought 1,237,421 Nuvalent shares in Q2 2026, an estimated $133M.
Nuvalent made up 0.03% of Barclays's portfolio in Q2 2026, its #379 holding.
Barclays first reported a position in Nuvalent in Q1 2022 and has held it in 18 quarters since.
293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.